...
首页> 外文期刊>Journal of Lipid Research >Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras.
【24h】

Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras.

机译:专题复习系列:脂质翻译后修饰。 CAAX修饰和Ras的膜靶向。

获取原文
获取原文并翻译 | 示例

摘要

Proteins that terminate with a consensus sequence known as CAAX undergo a series of posttranslational modifications that include polyisoprenylation, endoproteolysis, and carboxyl methylation. These modifications render otherwise hydrophilic proteins hydrophobic at their C termini such that they associate with membranes. Whereas prenylation occurs in the cytosol, postprenylation processing is accomplished on the cytoplasmic surface of the endoplasmic reticulum and Golgi apparatus. Among the numerous CAAX proteins encoded in mammalian genomes are many signaling molecules such as monomeric GTPases, including the Ras proteins that play an important role in cancer. In the course of their processing, nascent Ras proteins traffic from their site of synthesis in the cytosol to the endomembrane and then out to the plasma membrane (PM) by at least two pathways. Recently, retrograde pathways have been discovered that deliver mature Ras from the PM back to the Golgi. The Golgi has been identified as a platform upon which Ras can signal. Thus, the subcellular trafficking of Ras proteins has the potential to increase the complexity of Ras signaling by adding a spatial dimension. The complexity of Ras trafficking also affords a wider array of potential targets for the discovery of drugs that might inhibit tumors by interfering with Ras trafficking.
机译:以共有序列(称为CAAX)终止的蛋白质会经历一系列翻译后修饰,包括聚异戊二烯基化,内切蛋白水解和羧基甲基化。这些修饰使亲水性蛋白在其C末端具有疏水性,从而使其与膜结合。异戊二烯化发生在细胞质中,而异戊二烯化后的过程是在内质网和高尔基体的细胞质表面完成的。在哺乳动物基因组中编码的众多CAAX蛋白中,有许多信号分子,例如单体GTPases,包括在癌症中起重要作用的Ras蛋白。在其加工过程中,新生的Ras蛋白从其在细胞质溶胶中的合成位点运输到内膜,然后通过至少两种途径流出到质膜(PM)。最近,发现了逆行途径,可将成熟的Ras从PM输送回高尔基体。高尔基体被认为是Ras可以发信号的平台。因此,通过增加空间维度,Ras蛋白的亚细胞运输可能会增加Ras信号传导的复杂性。 Ras贩运的复杂性还为发现可能通过干扰Ras贩运抑制肿瘤的药物提供了更广泛的潜在目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号